Pharma Mar SA - Company Profile
Powered by
All the data and insights you need on Pharma Mar SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Pharma Mar SA Strategy Report
- Understand Pharma Mar SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Pharma Mar SA patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
IL295044A | Application | Antitumoral compounds | A61K31/4995; A61P35/00; C07D515/22; Y02P20/55 | September 01, 2022 |
ECSP22049008A | Application | M?TODOS DE TRATAMIENTO DEL C?NCER DE PULM?N DE C?LULAS PEQUE?AS CON FORMULACIONES DE LURBINECTEDINA | A61K31/4995; A61P35/00 | August 31, 2022 |
EP4047002A1 | Application | ANTITUMORVERBINDUNGEN | A61K31/4995; A61P35/00; C07D515/22; Y02P20/55 | August 24, 2022 |
KR1020220109495A | Application | Antitumoral compounds | A61K31/4995; A61P35/00; C07D515/22; Y02P20/55 | August 04, 2022 |
US20220242883A1 | Application | Antitumoral Compounds | A61P35/00; C07D515/22 | August 04, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer